Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study. Tunesi S, Du DL, Gualano G, Millet JP, et al. J Infect 2022;84:834-872.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tunesi S, Du DL, Gualano G, Millet JP, et al. Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study. J Infect 2022;84:834-872.
PMID: 35271917